nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGDR2—allergic rhinitis	0.463	1	CbGaD
Sulindac—osteoarthritis—Methylprednisolone—allergic rhinitis	0.267	1	CpDpCtD
Sulindac—PTGS1—Montelukast—allergic rhinitis	0.0273	0.182	CbGbCtD
Sulindac—PTGS1—Diphenhydramine—allergic rhinitis	0.0273	0.182	CbGbCtD
Sulindac—PTGS2—Triamcinolone—allergic rhinitis	0.0224	0.149	CbGbCtD
Sulindac—CYP1A2—Desloratadine—allergic rhinitis	0.0212	0.141	CbGbCtD
Sulindac—PTGS2—Betamethasone—allergic rhinitis	0.0192	0.128	CbGbCtD
Sulindac—CYP1A2—Diphenhydramine—allergic rhinitis	0.0122	0.0812	CbGbCtD
Sulindac—PTGS2—Dexamethasone—allergic rhinitis	0.0112	0.0744	CbGbCtD
Sulindac—CYP1A1—Dexamethasone—allergic rhinitis	0.00944	0.0628	CbGbCtD
Sulindac—PTGDR2—Eicosanoid ligand-binding receptors—CYSLTR1—allergic rhinitis	0.00355	0.162	CbGpPWpGaD
Sulindac—MAPK3—exocrine gland—allergic rhinitis	0.00207	0.101	CbGeAlD
Sulindac—AKR1B1—respiratory system—allergic rhinitis	0.00149	0.0724	CbGeAlD
Sulindac—AKR1B1—eye—allergic rhinitis	0.00136	0.0662	CbGeAlD
Sulindac—AKR1B1—epithelium—allergic rhinitis	0.00124	0.0605	CbGeAlD
Sulindac—AKR1B1—bronchus—allergic rhinitis	0.00123	0.0596	CbGeAlD
Sulindac—AKR1B1—trachea—allergic rhinitis	0.0011	0.0535	CbGeAlD
Sulindac—MAPK3—respiratory system—allergic rhinitis	0.00108	0.0525	CbGeAlD
Sulindac—MAPK3—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.00107	0.0487	CbGpPWpGaD
Sulindac—MAPK3—eye—allergic rhinitis	0.000987	0.048	CbGeAlD
Sulindac—MAPK3—epithelium—allergic rhinitis	0.000902	0.0439	CbGeAlD
Sulindac—MAPK3—bronchus—allergic rhinitis	0.000889	0.0432	CbGeAlD
Sulindac—MAPK3—skin of body—allergic rhinitis	0.000858	0.0417	CbGeAlD
Sulindac—MAPK3—trachea—allergic rhinitis	0.000798	0.0388	CbGeAlD
Sulindac—AKR1B1—lung—allergic rhinitis	0.000791	0.0385	CbGeAlD
Sulindac—PPARD—lung—allergic rhinitis	0.000622	0.0303	CbGeAlD
Sulindac—MAPK3—lung—allergic rhinitis	0.000573	0.0279	CbGeAlD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.000497	0.0227	CbGpPWpGaD
Sulindac—MAPK3—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.000467	0.0214	CbGpPWpGaD
Sulindac—MAPK3—IL17 signaling pathway—IL17A—allergic rhinitis	0.0004	0.0183	CbGpPWpGaD
Sulindac—MAPK3—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.000394	0.018	CbGpPWpGaD
Sulindac—MAPK3—Regulation of cytoplasmic and nuclear SMAD2/3 signaling—SMAD3—allergic rhinitis	0.000371	0.017	CbGpPWpGaD
Sulindac—PTGDR2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000364	0.0167	CbGpPWpGaD
Sulindac—CYP1A2—respiratory system—allergic rhinitis	0.000339	0.0165	CbGeAlD
Sulindac—CYP1A1—respiratory system—allergic rhinitis	0.000334	0.0162	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Flunisolide—allergic rhinitis	0.000332	0.213	CbGdCrCtD
Sulindac—MAPK3—Endothelins—CYSLTR1—allergic rhinitis	0.000323	0.0148	CbGpPWpGaD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000312	0.0143	CbGpPWpGaD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000301	0.0138	CbGpPWpGaD
Sulindac—PTGS1—respiratory system—allergic rhinitis	0.000293	0.0143	CbGeAlD
Sulindac—PTGS2—respiratory system—allergic rhinitis	0.00028	0.0136	CbGeAlD
Sulindac—CYP1A1—epithelium—allergic rhinitis	0.000279	0.0136	CbGeAlD
Sulindac—CYP1A1—bronchus—allergic rhinitis	0.000275	0.0134	CbGeAlD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.000268	0.0123	CbGpPWpGaD
Sulindac—MAPK3—Osteopontin Signaling—NFKB1—allergic rhinitis	0.000266	0.0122	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-2 signaling—IL5—allergic rhinitis	0.000266	0.0122	CbGpPWpGaD
Sulindac—CYP1A1—skin of body—allergic rhinitis	0.000265	0.0129	CbGeAlD
Sulindac—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—allergic rhinitis	0.00025	0.0114	CbGpPWpGaD
Sulindac—CYP1A1—trachea—allergic rhinitis	0.000247	0.012	CbGeAlD
Sulindac—PTGS1—epithelium—allergic rhinitis	0.000245	0.0119	CbGeAlD
Sulindac—PTGDR2—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000238	0.0109	CbGpPWpGaD
Sulindac—PTGS2—epithelium—allergic rhinitis	0.000234	0.0114	CbGeAlD
Sulindac—PTGS1—skin of body—allergic rhinitis	0.000233	0.0113	CbGeAlD
Sulindac—PTGS2—bronchus—allergic rhinitis	0.000231	0.0112	CbGeAlD
Sulindac—PTGDR2—GPCR ligand binding—CCL11—allergic rhinitis	0.00023	0.0105	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—PFN2—allergic rhinitis	0.000227	0.0104	CbGpPWpGaD
Sulindac—PPARD—Adipogenesis—ADIPOQ—allergic rhinitis	0.000224	0.0102	CbGpPWpGaD
Sulindac—PTGS2—skin of body—allergic rhinitis	0.000223	0.0108	CbGeAlD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000219	0.01	CbGpPWpGaD
Sulindac—PTGS1—trachea—allergic rhinitis	0.000217	0.0105	CbGeAlD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000212	0.00969	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.000209	0.00959	CbGpPWpGaD
Sulindac—PTGS2—trachea—allergic rhinitis	0.000207	0.0101	CbGeAlD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.000206	0.00942	CbGpPWpGaD
Sulindac—PTGS2—Fluticasone Propionate—Flunisolide—allergic rhinitis	0.0002	0.129	CbGdCrCtD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—IL13—allergic rhinitis	0.000199	0.00913	CbGpPWpGaD
Sulindac—CYP1A2—lung—allergic rhinitis	0.00018	0.00874	CbGeAlD
Sulindac—CYP1A1—lung—allergic rhinitis	0.000177	0.00863	CbGeAlD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—IL5—allergic rhinitis	0.000171	0.00781	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—IL17A—allergic rhinitis	0.00017	0.0078	CbGpPWpGaD
Sulindac—MAPK3—IL-4 Signaling Pathway—IL4—allergic rhinitis	0.000169	0.00776	CbGpPWpGaD
Sulindac—MAPK3—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000168	0.00768	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—TAC1—allergic rhinitis	0.000167	0.00763	CbGpPWpGaD
Sulindac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000166	0.00759	CbGpPWpGaD
Sulindac—PPARD—Adipogenesis—SMAD3—allergic rhinitis	0.000163	0.00744	CbGpPWpGaD
Sulindac—PTGS2—Fluocinonide—Methylprednisolone—allergic rhinitis	0.000162	0.104	CbGdCrCtD
Sulindac—MAPK3—Developmental Biology—PFN2—allergic rhinitis	0.000162	0.00742	CbGpPWpGaD
Sulindac—PTGS2—Fluocinonide—Dexamethasone—allergic rhinitis	0.00016	0.103	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Betamethasone—allergic rhinitis	0.00016	0.103	CbGdCrCtD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—ICAM1—allergic rhinitis	0.000159	0.00726	CbGpPWpGaD
Sulindac—PTGS2—Fluocinonide—Triamcinolone—allergic rhinitis	0.000156	0.1	CbGdCrCtD
Sulindac—PTGS1—lung—allergic rhinitis	0.000156	0.00758	CbGeAlD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000151	0.0069	CbGpPWpGaD
Sulindac—PTGS2—lung—allergic rhinitis	0.000149	0.00724	CbGeAlD
Sulindac—MAPK3—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.000143	0.00654	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000139	0.00638	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—IL5—allergic rhinitis	0.000137	0.00626	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000134	0.00615	CbGpPWpGaD
Sulindac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.000134	0.00614	CbGpPWpGaD
Sulindac—MAPK3—IL17 signaling pathway—NFKB1—allergic rhinitis	0.000133	0.00608	CbGpPWpGaD
Sulindac—MAPK3—Osteopontin-mediated events—NFKB1—allergic rhinitis	0.000133	0.00608	CbGpPWpGaD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000133	0.00607	CbGpPWpGaD
Sulindac—MAPK3—ALK1 signaling events—TGFB1—allergic rhinitis	0.000127	0.00583	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000122	0.00558	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—IL4—allergic rhinitis	0.000121	0.00555	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000121	0.00554	CbGpPWpGaD
Sulindac—MAPK3—Interferon Signaling—HLA-G—allergic rhinitis	0.000119	0.00543	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CCL11—allergic rhinitis	0.000118	0.00539	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.000107	0.00491	CbGpPWpGaD
Sulindac—MAPK3—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000104	0.00477	CbGpPWpGaD
Sulindac—MAPK3—Syndecan-2-mediated signaling events—TGFB1—allergic rhinitis	9.82e-05	0.0045	CbGpPWpGaD
Sulindac—PTGS2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	9.8e-05	0.063	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	9.64e-05	0.062	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Betamethasone—allergic rhinitis	9.64e-05	0.062	CbGdCrCtD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—ICAM1—allergic rhinitis	9.64e-05	0.00441	CbGpPWpGaD
Sulindac—MAPK3—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	9.53e-05	0.00436	CbGpPWpGaD
Sulindac—MAPK3—TSLP Signaling Pathway—NFKB1—allergic rhinitis	9.53e-05	0.00436	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—TAC1—allergic rhinitis	9.42e-05	0.00431	CbGpPWpGaD
Sulindac—PTGS2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	9.42e-05	0.0606	CbGdCrCtD
Sulindac—MAPK3—Syndecan-1-mediated signaling events—TGFB1—allergic rhinitis	9.41e-05	0.00431	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—NFKB1—allergic rhinitis	9.37e-05	0.00429	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—IL4—allergic rhinitis	9.07e-05	0.00415	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	9.07e-05	0.00415	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—IL5—allergic rhinitis	8.76e-05	0.00401	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—TAC1—allergic rhinitis	8.56e-05	0.00392	CbGpPWpGaD
Sulindac—MAPK3—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	8.53e-05	0.0039	CbGpPWpGaD
Sulindac—MAPK3—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	8.53e-05	0.0039	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	8.49e-05	0.00388	CbGpPWpGaD
Sulindac—MAPK3—IL-1 signaling pathway—NFKB1—allergic rhinitis	8.4e-05	0.00384	CbGpPWpGaD
Sulindac—MAPK3—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	8.4e-05	0.00384	CbGpPWpGaD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	8.4e-05	0.00384	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—TGFB1—allergic rhinitis	8.37e-05	0.00383	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MS4A2—allergic rhinitis	8.23e-05	0.00377	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL5—allergic rhinitis	7.96e-05	0.00364	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	7.92e-05	0.00363	CbGpPWpGaD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	7.73e-05	0.00354	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	7.72e-05	0.00353	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—TGFB1—allergic rhinitis	7.68e-05	0.00351	CbGpPWpGaD
Sulindac—MAPK3—Interferon Signaling—HLA-DQB1—allergic rhinitis	7.41e-05	0.00339	CbGpPWpGaD
Sulindac—CYP1A1—Melatonin metabolism and effects—NFKB1—allergic rhinitis	7.4e-05	0.00339	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	7.35e-05	0.00336	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—NFKB1—allergic rhinitis	7.26e-05	0.00332	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—ICAM1—allergic rhinitis	7.2e-05	0.0033	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CYSLTR1—allergic rhinitis	7.2e-05	0.0033	CbGpPWpGaD
Sulindac—CYP1A1—Oxidative Stress—NFKB1—allergic rhinitis	7.2e-05	0.0033	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—allergic rhinitis	7.17e-05	0.00328	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—NFKB1—allergic rhinitis	7.17e-05	0.00328	CbGpPWpGaD
Sulindac—Dizziness—Cetirizine—allergic rhinitis	7.1e-05	0.000934	CcSEcCtD
Sulindac—MAPK3—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	7.1e-05	0.00325	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—NFKB1—allergic rhinitis	7.09e-05	0.00324	CbGpPWpGaD
Sulindac—Neuropathy peripheral—Triamcinolone—allergic rhinitis	7.04e-05	0.000925	CcSEcCtD
Sulindac—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	7.02e-05	0.000923	CcSEcCtD
Sulindac—MAPK3—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	7e-05	0.0032	CbGpPWpGaD
Sulindac—Dizziness—Flunisolide—allergic rhinitis	6.98e-05	0.000918	CcSEcCtD
Sulindac—Conjunctivitis—Triamcinolone—allergic rhinitis	6.98e-05	0.000917	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—CCL11—allergic rhinitis	6.96e-05	0.00318	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL4—allergic rhinitis	6.95e-05	0.00318	CbGpPWpGaD
Sulindac—PPARD—Adipogenesis—TGFB1—allergic rhinitis	6.89e-05	0.00315	CbGpPWpGaD
Sulindac—Sweating—Methylprednisolone—allergic rhinitis	6.87e-05	0.000903	CcSEcCtD
Sulindac—Vomiting—Cetirizine—allergic rhinitis	6.83e-05	0.000898	CcSEcCtD
Sulindac—PTGS1—Selenium Micronutrient Network—ICAM1—allergic rhinitis	6.82e-05	0.00312	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	6.78e-05	0.0031	CbGpPWpGaD
Sulindac—Nausea—Loratadine—allergic rhinitis	6.78e-05	0.000891	CcSEcCtD
Sulindac—Epistaxis—Triamcinolone—allergic rhinitis	6.77e-05	0.00089	CcSEcCtD
Sulindac—Rash—Cetirizine—allergic rhinitis	6.77e-05	0.00089	CcSEcCtD
Sulindac—Dermatitis—Cetirizine—allergic rhinitis	6.77e-05	0.000889	CcSEcCtD
Sulindac—Visual impairment—Prednisolone—allergic rhinitis	6.75e-05	0.000888	CcSEcCtD
Sulindac—Headache—Cetirizine—allergic rhinitis	6.73e-05	0.000884	CcSEcCtD
Sulindac—Vomiting—Flunisolide—allergic rhinitis	6.71e-05	0.000883	CcSEcCtD
Sulindac—Rash—Flunisolide—allergic rhinitis	6.66e-05	0.000875	CcSEcCtD
Sulindac—Dermatitis—Flunisolide—allergic rhinitis	6.65e-05	0.000874	CcSEcCtD
Sulindac—Hypersensitivity—Montelukast—allergic rhinitis	6.64e-05	0.000872	CcSEcCtD
Sulindac—Headache—Flunisolide—allergic rhinitis	6.62e-05	0.00087	CcSEcCtD
Sulindac—Hyperglycaemia—Betamethasone—allergic rhinitis	6.59e-05	0.000866	CcSEcCtD
Sulindac—Hyperglycaemia—Dexamethasone—allergic rhinitis	6.59e-05	0.000866	CcSEcCtD
Sulindac—MAPK3—TCR Signaling Pathway—CD4—allergic rhinitis	6.58e-05	0.00301	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	6.55e-05	0.003	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—NFKB1—allergic rhinitis	6.55e-05	0.003	CbGpPWpGaD
Sulindac—Asthenia—Montelukast—allergic rhinitis	6.46e-05	0.000849	CcSEcCtD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL5—allergic rhinitis	6.39e-05	0.00292	CbGpPWpGaD
Sulindac—Neuropathy peripheral—Betamethasone—allergic rhinitis	6.39e-05	0.00084	CcSEcCtD
Sulindac—Neuropathy peripheral—Dexamethasone—allergic rhinitis	6.39e-05	0.00084	CcSEcCtD
Sulindac—Nausea—Cetirizine—allergic rhinitis	6.38e-05	0.000839	CcSEcCtD
Sulindac—Pruritus—Montelukast—allergic rhinitis	6.37e-05	0.000838	CcSEcCtD
Sulindac—Conjunctivitis—Dexamethasone—allergic rhinitis	6.33e-05	0.000832	CcSEcCtD
Sulindac—Conjunctivitis—Betamethasone—allergic rhinitis	6.33e-05	0.000832	CcSEcCtD
Sulindac—PPARD—NRF2 pathway—TGFB1—allergic rhinitis	6.28e-05	0.00287	CbGpPWpGaD
Sulindac—Nausea—Flunisolide—allergic rhinitis	6.27e-05	0.000825	CcSEcCtD
Sulindac—Arrhythmia—Prednisolone—allergic rhinitis	6.26e-05	0.000823	CcSEcCtD
Sulindac—Visual impairment—Methylprednisolone—allergic rhinitis	6.2e-05	0.000815	CcSEcCtD
Sulindac—Diarrhoea—Montelukast—allergic rhinitis	6.16e-05	0.00081	CcSEcCtD
Sulindac—Arrhythmia—Hydrocortisone—allergic rhinitis	6.12e-05	0.000804	CcSEcCtD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—NFKB1—allergic rhinitis	6.1e-05	0.00279	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	5.99e-05	0.00274	CbGpPWpGaD
Sulindac—Dizziness—Montelukast—allergic rhinitis	5.96e-05	0.000783	CcSEcCtD
Sulindac—PPARD—Generic Transcription Pathway—SMAD3—allergic rhinitis	5.94e-05	0.00272	CbGpPWpGaD
Sulindac—MAPK3—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	5.93e-05	0.00271	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—TGFB1—allergic rhinitis	5.91e-05	0.0027	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	5.88e-05	0.00269	CbGpPWpGaD
Sulindac—MAPK3—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	5.77e-05	0.00264	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	5.76e-05	0.00264	CbGpPWpGaD
Sulindac—Arrhythmia—Triamcinolone—allergic rhinitis	5.76e-05	0.000757	CcSEcCtD
Sulindac—Vision blurred—Prednisolone—allergic rhinitis	5.75e-05	0.000756	CcSEcCtD
Sulindac—Arrhythmia—Methylprednisolone—allergic rhinitis	5.75e-05	0.000755	CcSEcCtD
Sulindac—Vomiting—Montelukast—allergic rhinitis	5.73e-05	0.000753	CcSEcCtD
Sulindac—Rash—Montelukast—allergic rhinitis	5.68e-05	0.000747	CcSEcCtD
Sulindac—Dermatitis—Montelukast—allergic rhinitis	5.67e-05	0.000746	CcSEcCtD
Sulindac—MAPK3—TCR Signaling Pathway—NFKB1—allergic rhinitis	5.67e-05	0.00259	CbGpPWpGaD
Sulindac—Ill-defined disorder—Prednisolone—allergic rhinitis	5.66e-05	0.000744	CcSEcCtD
Sulindac—Headache—Montelukast—allergic rhinitis	5.64e-05	0.000742	CcSEcCtD
Sulindac—Visual impairment—Dexamethasone—allergic rhinitis	5.64e-05	0.000741	CcSEcCtD
Sulindac—Visual impairment—Betamethasone—allergic rhinitis	5.64e-05	0.000741	CcSEcCtD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	5.62e-05	0.00257	CbGpPWpGaD
Sulindac—Angioedema—Prednisolone—allergic rhinitis	5.58e-05	0.000733	CcSEcCtD
Sulindac—MAPK3—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	5.57e-05	0.00255	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	5.57e-05	0.00255	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	5.57e-05	0.00255	CbGpPWpGaD
Sulindac—Ill-defined disorder—Hydrocortisone—allergic rhinitis	5.53e-05	0.000727	CcSEcCtD
Sulindac—ALB—Folate Metabolism—ICAM1—allergic rhinitis	5.52e-05	0.00253	CbGpPWpGaD
Sulindac—Malaise—Prednisolone—allergic rhinitis	5.5e-05	0.000723	CcSEcCtD
Sulindac—Dysgeusia—Triamcinolone—allergic rhinitis	5.49e-05	0.000722	CcSEcCtD
Sulindac—Vertigo—Prednisolone—allergic rhinitis	5.48e-05	0.000721	CcSEcCtD
Sulindac—Syncope—Prednisolone—allergic rhinitis	5.47e-05	0.000719	CcSEcCtD
Sulindac—MAPK3—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	5.47e-05	0.0025	CbGpPWpGaD
Sulindac—Angioedema—Hydrocortisone—allergic rhinitis	5.45e-05	0.000716	CcSEcCtD
Sulindac—PTGS2—Selenium Micronutrient Network—ICAM1—allergic rhinitis	5.42e-05	0.00248	CbGpPWpGaD
Sulindac—MAPK3—Interferon Signaling—ICAM1—allergic rhinitis	5.41e-05	0.00247	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL4—allergic rhinitis	5.39e-05	0.00247	CbGpPWpGaD
Sulindac—Malaise—Hydrocortisone—allergic rhinitis	5.37e-05	0.000706	CcSEcCtD
Sulindac—Loss of consciousness—Prednisolone—allergic rhinitis	5.36e-05	0.000705	CcSEcCtD
Sulindac—Vertigo—Hydrocortisone—allergic rhinitis	5.35e-05	0.000704	CcSEcCtD
Sulindac—Nausea—Montelukast—allergic rhinitis	5.35e-05	0.000703	CcSEcCtD
Sulindac—Syncope—Hydrocortisone—allergic rhinitis	5.34e-05	0.000703	CcSEcCtD
Sulindac—Convulsion—Prednisolone—allergic rhinitis	5.29e-05	0.000695	CcSEcCtD
Sulindac—Hypertension—Prednisolone—allergic rhinitis	5.27e-05	0.000693	CcSEcCtD
Sulindac—MAPK3—MyD88-independent cascade—NFKB1—allergic rhinitis	5.25e-05	0.0024	CbGpPWpGaD
Sulindac—Loss of consciousness—Hydrocortisone—allergic rhinitis	5.24e-05	0.000689	CcSEcCtD
Sulindac—Arrhythmia—Betamethasone—allergic rhinitis	5.22e-05	0.000687	CcSEcCtD
Sulindac—Arrhythmia—Dexamethasone—allergic rhinitis	5.22e-05	0.000687	CcSEcCtD
Sulindac—Ill-defined disorder—Triamcinolone—allergic rhinitis	5.21e-05	0.000684	CcSEcCtD
Sulindac—Ill-defined disorder—Methylprednisolone—allergic rhinitis	5.19e-05	0.000683	CcSEcCtD
Sulindac—Alopecia—Dexamethasone—allergic rhinitis	5.17e-05	0.000679	CcSEcCtD
Sulindac—Alopecia—Betamethasone—allergic rhinitis	5.17e-05	0.000679	CcSEcCtD
Sulindac—Convulsion—Hydrocortisone—allergic rhinitis	5.16e-05	0.000679	CcSEcCtD
Sulindac—Hypertension—Hydrocortisone—allergic rhinitis	5.14e-05	0.000676	CcSEcCtD
Sulindac—Discomfort—Prednisolone—allergic rhinitis	5.13e-05	0.000675	CcSEcCtD
Sulindac—Angioedema—Triamcinolone—allergic rhinitis	5.13e-05	0.000674	CcSEcCtD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	5.13e-05	0.00235	CbGpPWpGaD
Sulindac—Angioedema—Methylprednisolone—allergic rhinitis	5.12e-05	0.000673	CcSEcCtD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	5.12e-05	0.00234	CbGpPWpGaD
Sulindac—Myalgia—Hydrocortisone—allergic rhinitis	5.07e-05	0.000667	CcSEcCtD
Sulindac—Malaise—Triamcinolone—allergic rhinitis	5.06e-05	0.000665	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—TAC1—allergic rhinitis	5.06e-05	0.00231	CbGpPWpGaD
Sulindac—Malaise—Methylprednisolone—allergic rhinitis	5.05e-05	0.000664	CcSEcCtD
Sulindac—Vertigo—Triamcinolone—allergic rhinitis	5.04e-05	0.000663	CcSEcCtD
Sulindac—Syncope—Triamcinolone—allergic rhinitis	5.03e-05	0.000661	CcSEcCtD
Sulindac—Vertigo—Methylprednisolone—allergic rhinitis	5.03e-05	0.000661	CcSEcCtD
Sulindac—Syncope—Methylprednisolone—allergic rhinitis	5.02e-05	0.00066	CcSEcCtD
Sulindac—Discomfort—Hydrocortisone—allergic rhinitis	5.01e-05	0.000659	CcSEcCtD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—NFKB1—allergic rhinitis	5.01e-05	0.00229	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	4.99e-05	0.00228	CbGpPWpGaD
Sulindac—Anaphylactic shock—Prednisolone—allergic rhinitis	4.98e-05	0.000655	CcSEcCtD
Sulindac—Oedema—Prednisolone—allergic rhinitis	4.98e-05	0.000655	CcSEcCtD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	4.95e-05	0.00226	CbGpPWpGaD
Sulindac—Loss of consciousness—Triamcinolone—allergic rhinitis	4.93e-05	0.000648	CcSEcCtD
Sulindac—Loss of consciousness—Methylprednisolone—allergic rhinitis	4.92e-05	0.000647	CcSEcCtD
Sulindac—Shock—Prednisolone—allergic rhinitis	4.9e-05	0.000644	CcSEcCtD
Sulindac—MAPK3—Signaling by Interleukins—NFKB1—allergic rhinitis	4.9e-05	0.00224	CbGpPWpGaD
Sulindac—Oedema—Hydrocortisone—allergic rhinitis	4.86e-05	0.000639	CcSEcCtD
Sulindac—Anaphylactic shock—Hydrocortisone—allergic rhinitis	4.86e-05	0.000639	CcSEcCtD
Sulindac—Convulsion—Triamcinolone—allergic rhinitis	4.86e-05	0.000639	CcSEcCtD
Sulindac—Tachycardia—Prednisolone—allergic rhinitis	4.86e-05	0.000639	CcSEcCtD
Sulindac—Convulsion—Methylprednisolone—allergic rhinitis	4.85e-05	0.000638	CcSEcCtD
Sulindac—Hypertension—Triamcinolone—allergic rhinitis	4.84e-05	0.000637	CcSEcCtD
Sulindac—Hypertension—Methylprednisolone—allergic rhinitis	4.83e-05	0.000635	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisolone—allergic rhinitis	4.81e-05	0.000633	CcSEcCtD
Sulindac—MAPK3—Immune System—MS4A2—allergic rhinitis	4.79e-05	0.00219	CbGpPWpGaD
Sulindac—Shock—Hydrocortisone—allergic rhinitis	4.78e-05	0.000629	CcSEcCtD
Sulindac—Myalgia—Triamcinolone—allergic rhinitis	4.78e-05	0.000628	CcSEcCtD
Sulindac—Myalgia—Methylprednisolone—allergic rhinitis	4.77e-05	0.000627	CcSEcCtD
Sulindac—Arthralgia—Methylprednisolone—allergic rhinitis	4.77e-05	0.000627	CcSEcCtD
Sulindac—Tachycardia—Hydrocortisone—allergic rhinitis	4.75e-05	0.000624	CcSEcCtD
Sulindac—Ill-defined disorder—Dexamethasone—allergic rhinitis	4.72e-05	0.000621	CcSEcCtD
Sulindac—Ill-defined disorder—Betamethasone—allergic rhinitis	4.72e-05	0.000621	CcSEcCtD
Sulindac—MAPK3—Activated TLR4 signalling—NFKB1—allergic rhinitis	4.72e-05	0.00216	CbGpPWpGaD
Sulindac—Discomfort—Triamcinolone—allergic rhinitis	4.72e-05	0.00062	CcSEcCtD
Sulindac—MAPK3—TCR Signaling Pathway—TGFB1—allergic rhinitis	4.72e-05	0.00216	CbGpPWpGaD
Sulindac—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	4.72e-05	0.00216	CbGpPWpGaD
Sulindac—Discomfort—Methylprednisolone—allergic rhinitis	4.71e-05	0.000619	CcSEcCtD
Sulindac—Hyperhidrosis—Hydrocortisone—allergic rhinitis	4.7e-05	0.000618	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—IL5—allergic rhinitis	4.7e-05	0.00215	CbGpPWpGaD
Sulindac—Angioedema—Betamethasone—allergic rhinitis	4.65e-05	0.000612	CcSEcCtD
Sulindac—Angioedema—Dexamethasone—allergic rhinitis	4.65e-05	0.000612	CcSEcCtD
Sulindac—MAPK3—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	4.64e-05	0.00212	CbGpPWpGaD
Sulindac—Anorexia—Hydrocortisone—allergic rhinitis	4.64e-05	0.000609	CcSEcCtD
Sulindac—Malaise—Betamethasone—allergic rhinitis	4.59e-05	0.000604	CcSEcCtD
Sulindac—Malaise—Dexamethasone—allergic rhinitis	4.59e-05	0.000604	CcSEcCtD
Sulindac—Anaphylactic shock—Triamcinolone—allergic rhinitis	4.58e-05	0.000602	CcSEcCtD
Sulindac—Oedema—Triamcinolone—allergic rhinitis	4.58e-05	0.000602	CcSEcCtD
Sulindac—Vertigo—Betamethasone—allergic rhinitis	4.57e-05	0.000601	CcSEcCtD
Sulindac—Vertigo—Dexamethasone—allergic rhinitis	4.57e-05	0.000601	CcSEcCtD
Sulindac—Anaphylactic shock—Methylprednisolone—allergic rhinitis	4.57e-05	0.000601	CcSEcCtD
Sulindac—Syncope—Betamethasone—allergic rhinitis	4.57e-05	0.0006	CcSEcCtD
Sulindac—Syncope—Dexamethasone—allergic rhinitis	4.57e-05	0.0006	CcSEcCtD
Sulindac—Hypotension—Hydrocortisone—allergic rhinitis	4.54e-05	0.000597	CcSEcCtD
Sulindac—Shock—Triamcinolone—allergic rhinitis	4.51e-05	0.000592	CcSEcCtD
Sulindac—Insomnia—Prednisolone—allergic rhinitis	4.5e-05	0.000592	CcSEcCtD
Sulindac—Shock—Methylprednisolone—allergic rhinitis	4.5e-05	0.000591	CcSEcCtD
Sulindac—Loss of consciousness—Dexamethasone—allergic rhinitis	4.47e-05	0.000588	CcSEcCtD
Sulindac—Loss of consciousness—Betamethasone—allergic rhinitis	4.47e-05	0.000588	CcSEcCtD
Sulindac—Paraesthesia—Prednisolone—allergic rhinitis	4.47e-05	0.000588	CcSEcCtD
Sulindac—Tachycardia—Triamcinolone—allergic rhinitis	4.47e-05	0.000588	CcSEcCtD
Sulindac—MAPK3—Signaling by GPCR—PTGDR2—allergic rhinitis	4.46e-05	0.00204	CbGpPWpGaD
Sulindac—Tachycardia—Methylprednisolone—allergic rhinitis	4.46e-05	0.000586	CcSEcCtD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	4.44e-05	0.00203	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	4.43e-05	0.000582	CcSEcCtD
Sulindac—Hyperhidrosis—Triamcinolone—allergic rhinitis	4.43e-05	0.000582	CcSEcCtD
Sulindac—Hyperhidrosis—Methylprednisolone—allergic rhinitis	4.42e-05	0.000581	CcSEcCtD
Sulindac—Convulsion—Dexamethasone—allergic rhinitis	4.41e-05	0.00058	CcSEcCtD
Sulindac—Convulsion—Betamethasone—allergic rhinitis	4.41e-05	0.00058	CcSEcCtD
Sulindac—Insomnia—Hydrocortisone—allergic rhinitis	4.4e-05	0.000578	CcSEcCtD
Sulindac—Hypertension—Dexamethasone—allergic rhinitis	4.4e-05	0.000578	CcSEcCtD
Sulindac—Hypertension—Betamethasone—allergic rhinitis	4.4e-05	0.000578	CcSEcCtD
Sulindac—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	4.38e-05	0.00201	CbGpPWpGaD
Sulindac—Paraesthesia—Hydrocortisone—allergic rhinitis	4.37e-05	0.000574	CcSEcCtD
Sulindac—Myalgia—Betamethasone—allergic rhinitis	4.33e-05	0.00057	CcSEcCtD
Sulindac—Myalgia—Dexamethasone—allergic rhinitis	4.33e-05	0.00057	CcSEcCtD
Sulindac—PTGS1—Selenium Micronutrient Network—NFKB1—allergic rhinitis	4.32e-05	0.00198	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	4.29e-05	0.00197	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—ICAM1—allergic rhinitis	4.28e-05	0.00196	CbGpPWpGaD
Sulindac—Discomfort—Dexamethasone—allergic rhinitis	4.28e-05	0.000563	CcSEcCtD
Sulindac—Discomfort—Betamethasone—allergic rhinitis	4.28e-05	0.000563	CcSEcCtD
Sulindac—Dyspepsia—Hydrocortisone—allergic rhinitis	4.28e-05	0.000563	CcSEcCtD
Sulindac—Hypotension—Methylprednisolone—allergic rhinitis	4.27e-05	0.000561	CcSEcCtD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	4.26e-05	0.00195	CbGpPWpGaD
Sulindac—Decreased appetite—Hydrocortisone—allergic rhinitis	4.23e-05	0.000556	CcSEcCtD
Sulindac—Fatigue—Hydrocortisone—allergic rhinitis	4.19e-05	0.000551	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	4.17e-05	0.000548	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	4.16e-05	0.000547	CcSEcCtD
Sulindac—Anaphylactic shock—Dexamethasone—allergic rhinitis	4.16e-05	0.000546	CcSEcCtD
Sulindac—Anaphylactic shock—Betamethasone—allergic rhinitis	4.16e-05	0.000546	CcSEcCtD
Sulindac—Oedema—Dexamethasone—allergic rhinitis	4.16e-05	0.000546	CcSEcCtD
Sulindac—Oedema—Betamethasone—allergic rhinitis	4.16e-05	0.000546	CcSEcCtD
Sulindac—Insomnia—Triamcinolone—allergic rhinitis	4.14e-05	0.000544	CcSEcCtD
Sulindac—Insomnia—Methylprednisolone—allergic rhinitis	4.13e-05	0.000543	CcSEcCtD
Sulindac—PTGS2—C-MYB transcription factor network—CD4—allergic rhinitis	4.13e-05	0.00189	CbGpPWpGaD
Sulindac—Paraesthesia—Triamcinolone—allergic rhinitis	4.11e-05	0.000541	CcSEcCtD
Sulindac—Feeling abnormal—Prednisolone—allergic rhinitis	4.1e-05	0.000539	CcSEcCtD
Sulindac—Paraesthesia—Methylprednisolone—allergic rhinitis	4.1e-05	0.000539	CcSEcCtD
Sulindac—Shock—Betamethasone—allergic rhinitis	4.09e-05	0.000537	CcSEcCtD
Sulindac—Shock—Dexamethasone—allergic rhinitis	4.09e-05	0.000537	CcSEcCtD
Sulindac—Dyspnoea—Triamcinolone—allergic rhinitis	4.08e-05	0.000537	CcSEcCtD
Sulindac—Thrombocytopenia—Dexamethasone—allergic rhinitis	4.07e-05	0.000535	CcSEcCtD
Sulindac—Thrombocytopenia—Betamethasone—allergic rhinitis	4.07e-05	0.000535	CcSEcCtD
Sulindac—Tachycardia—Betamethasone—allergic rhinitis	4.06e-05	0.000533	CcSEcCtD
Sulindac—Tachycardia—Dexamethasone—allergic rhinitis	4.06e-05	0.000533	CcSEcCtD
Sulindac—Dyspepsia—Triamcinolone—allergic rhinitis	4.03e-05	0.00053	CcSEcCtD
Sulindac—Dyspepsia—Methylprednisolone—allergic rhinitis	4.02e-05	0.000529	CcSEcCtD
Sulindac—Hyperhidrosis—Betamethasone—allergic rhinitis	4.02e-05	0.000528	CcSEcCtD
Sulindac—Hyperhidrosis—Dexamethasone—allergic rhinitis	4.02e-05	0.000528	CcSEcCtD
Sulindac—Feeling abnormal—Hydrocortisone—allergic rhinitis	4.01e-05	0.000527	CcSEcCtD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	4e-05	0.00183	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL5—allergic rhinitis	3.98e-05	0.00182	CbGpPWpGaD
Sulindac—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	3.98e-05	0.000523	CcSEcCtD
Sulindac—Anorexia—Betamethasone—allergic rhinitis	3.96e-05	0.000521	CcSEcCtD
Sulindac—Anorexia—Dexamethasone—allergic rhinitis	3.96e-05	0.000521	CcSEcCtD
Sulindac—Urticaria—Prednisolone—allergic rhinitis	3.96e-05	0.00052	CcSEcCtD
Sulindac—MAPK3—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	3.96e-05	0.00181	CbGpPWpGaD
Sulindac—Fatigue—Triamcinolone—allergic rhinitis	3.95e-05	0.000519	CcSEcCtD
Sulindac—Fatigue—Methylprednisolone—allergic rhinitis	3.94e-05	0.000518	CcSEcCtD
Sulindac—MAPK3—Developmental Biology—ADIPOQ—allergic rhinitis	3.93e-05	0.0018	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—NFKB1—allergic rhinitis	3.89e-05	0.00178	CbGpPWpGaD
Sulindac—Hypotension—Dexamethasone—allergic rhinitis	3.88e-05	0.00051	CcSEcCtD
Sulindac—Hypotension—Betamethasone—allergic rhinitis	3.88e-05	0.00051	CcSEcCtD
Sulindac—Urticaria—Hydrocortisone—allergic rhinitis	3.86e-05	0.000508	CcSEcCtD
Sulindac—Body temperature increased—Hydrocortisone—allergic rhinitis	3.84e-05	0.000505	CcSEcCtD
Sulindac—MAPK3—Spinal Cord Injury—TGFB1—allergic rhinitis	3.8e-05	0.00174	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	3.79e-05	0.000498	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	3.79e-05	0.000498	CcSEcCtD
Sulindac—Feeling abnormal—Triamcinolone—allergic rhinitis	3.77e-05	0.000496	CcSEcCtD
Sulindac—Feeling abnormal—Methylprednisolone—allergic rhinitis	3.77e-05	0.000495	CcSEcCtD
Sulindac—Insomnia—Betamethasone—allergic rhinitis	3.76e-05	0.000494	CcSEcCtD
Sulindac—Insomnia—Dexamethasone—allergic rhinitis	3.76e-05	0.000494	CcSEcCtD
Sulindac—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	3.74e-05	0.000491	CcSEcCtD
Sulindac—Paraesthesia—Dexamethasone—allergic rhinitis	3.73e-05	0.00049	CcSEcCtD
Sulindac—Paraesthesia—Betamethasone—allergic rhinitis	3.73e-05	0.00049	CcSEcCtD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	3.71e-05	0.0017	CbGpPWpGaD
Sulindac—Hypersensitivity—Prednisolone—allergic rhinitis	3.67e-05	0.000482	CcSEcCtD
Sulindac—Dyspepsia—Betamethasone—allergic rhinitis	3.66e-05	0.000481	CcSEcCtD
Sulindac—Dyspepsia—Dexamethasone—allergic rhinitis	3.66e-05	0.000481	CcSEcCtD
Sulindac—Urticaria—Triamcinolone—allergic rhinitis	3.64e-05	0.000478	CcSEcCtD
Sulindac—Urticaria—Methylprednisolone—allergic rhinitis	3.63e-05	0.000477	CcSEcCtD
Sulindac—Body temperature increased—Triamcinolone—allergic rhinitis	3.62e-05	0.000476	CcSEcCtD
Sulindac—Decreased appetite—Betamethasone—allergic rhinitis	3.61e-05	0.000475	CcSEcCtD
Sulindac—Decreased appetite—Dexamethasone—allergic rhinitis	3.61e-05	0.000475	CcSEcCtD
Sulindac—MAPK3—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	3.61e-05	0.00165	CbGpPWpGaD
Sulindac—Hypersensitivity—Hydrocortisone—allergic rhinitis	3.58e-05	0.000471	CcSEcCtD
Sulindac—Fatigue—Betamethasone—allergic rhinitis	3.58e-05	0.000471	CcSEcCtD
Sulindac—Fatigue—Dexamethasone—allergic rhinitis	3.58e-05	0.000471	CcSEcCtD
Sulindac—MAPK3—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.5e-05	0.0016	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—NFKB1—allergic rhinitis	3.49e-05	0.0016	CbGpPWpGaD
Sulindac—Asthenia—Hydrocortisone—allergic rhinitis	3.49e-05	0.000459	CcSEcCtD
Sulindac—Pruritus—Hydrocortisone—allergic rhinitis	3.44e-05	0.000452	CcSEcCtD
Sulindac—MAPK3—MAPK Signaling Pathway—NFKB1—allergic rhinitis	3.44e-05	0.00157	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—NFKB1—allergic rhinitis	3.43e-05	0.00157	CbGpPWpGaD
Sulindac—Feeling abnormal—Dexamethasone—allergic rhinitis	3.42e-05	0.00045	CcSEcCtD
Sulindac—Feeling abnormal—Betamethasone—allergic rhinitis	3.42e-05	0.00045	CcSEcCtD
Sulindac—Gastrointestinal pain—Betamethasone—allergic rhinitis	3.4e-05	0.000447	CcSEcCtD
Sulindac—Gastrointestinal pain—Dexamethasone—allergic rhinitis	3.4e-05	0.000447	CcSEcCtD
Sulindac—MAPK3—Signaling by GPCR—CCL11—allergic rhinitis	3.38e-05	0.00155	CbGpPWpGaD
Sulindac—Hypersensitivity—Triamcinolone—allergic rhinitis	3.37e-05	0.000444	CcSEcCtD
Sulindac—Hypersensitivity—Methylprednisolone—allergic rhinitis	3.37e-05	0.000443	CcSEcCtD
Sulindac—Diarrhoea—Hydrocortisone—allergic rhinitis	3.33e-05	0.000437	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—SMAD3—allergic rhinitis	3.31e-05	0.00151	CbGpPWpGaD
Sulindac—Urticaria—Betamethasone—allergic rhinitis	3.3e-05	0.000434	CcSEcCtD
Sulindac—Urticaria—Dexamethasone—allergic rhinitis	3.3e-05	0.000434	CcSEcCtD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	3.3e-05	0.00151	CbGpPWpGaD
Sulindac—Dizziness—Prednisolone—allergic rhinitis	3.29e-05	0.000433	CcSEcCtD
Sulindac—Asthenia—Triamcinolone—allergic rhinitis	3.29e-05	0.000432	CcSEcCtD
Sulindac—Body temperature increased—Betamethasone—allergic rhinitis	3.28e-05	0.000432	CcSEcCtD
Sulindac—Body temperature increased—Dexamethasone—allergic rhinitis	3.28e-05	0.000432	CcSEcCtD
Sulindac—Asthenia—Methylprednisolone—allergic rhinitis	3.28e-05	0.000431	CcSEcCtD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	3.26e-05	0.00149	CbGpPWpGaD
Sulindac—Pruritus—Triamcinolone—allergic rhinitis	3.24e-05	0.000426	CcSEcCtD
Sulindac—Pruritus—Methylprednisolone—allergic rhinitis	3.23e-05	0.000425	CcSEcCtD
Sulindac—Dizziness—Hydrocortisone—allergic rhinitis	3.22e-05	0.000423	CcSEcCtD
Sulindac—MAPK3—Cellular Senescence—NFKB1—allergic rhinitis	3.17e-05	0.00145	CbGpPWpGaD
Sulindac—Rash—Prednisolone—allergic rhinitis	3.14e-05	0.000413	CcSEcCtD
Sulindac—Dermatitis—Prednisolone—allergic rhinitis	3.14e-05	0.000412	CcSEcCtD
Sulindac—Diarrhoea—Methylprednisolone—allergic rhinitis	3.13e-05	0.000411	CcSEcCtD
Sulindac—Headache—Prednisolone—allergic rhinitis	3.12e-05	0.00041	CcSEcCtD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.1e-05	0.00142	CbGpPWpGaD
Sulindac—Vomiting—Hydrocortisone—allergic rhinitis	3.09e-05	0.000407	CcSEcCtD
Sulindac—Rash—Hydrocortisone—allergic rhinitis	3.07e-05	0.000403	CcSEcCtD
Sulindac—Dermatitis—Hydrocortisone—allergic rhinitis	3.06e-05	0.000403	CcSEcCtD
Sulindac—Headache—Hydrocortisone—allergic rhinitis	3.05e-05	0.000401	CcSEcCtD
Sulindac—Dizziness—Triamcinolone—allergic rhinitis	3.03e-05	0.000398	CcSEcCtD
Sulindac—Dizziness—Methylprednisolone—allergic rhinitis	3.02e-05	0.000397	CcSEcCtD
Sulindac—Asthenia—Betamethasone—allergic rhinitis	2.98e-05	0.000392	CcSEcCtD
Sulindac—Asthenia—Dexamethasone—allergic rhinitis	2.98e-05	0.000392	CcSEcCtD
Sulindac—Nausea—Prednisolone—allergic rhinitis	2.96e-05	0.000389	CcSEcCtD
Sulindac—Pruritus—Dexamethasone—allergic rhinitis	2.94e-05	0.000386	CcSEcCtD
Sulindac—Pruritus—Betamethasone—allergic rhinitis	2.94e-05	0.000386	CcSEcCtD
Sulindac—Vomiting—Triamcinolone—allergic rhinitis	2.91e-05	0.000383	CcSEcCtD
Sulindac—Vomiting—Methylprednisolone—allergic rhinitis	2.91e-05	0.000382	CcSEcCtD
Sulindac—Nausea—Hydrocortisone—allergic rhinitis	2.89e-05	0.00038	CcSEcCtD
Sulindac—Rash—Triamcinolone—allergic rhinitis	2.89e-05	0.00038	CcSEcCtD
Sulindac—Dermatitis—Triamcinolone—allergic rhinitis	2.88e-05	0.000379	CcSEcCtD
Sulindac—Rash—Methylprednisolone—allergic rhinitis	2.88e-05	0.000379	CcSEcCtD
Sulindac—Dermatitis—Methylprednisolone—allergic rhinitis	2.88e-05	0.000378	CcSEcCtD
Sulindac—Headache—Triamcinolone—allergic rhinitis	2.87e-05	0.000377	CcSEcCtD
Sulindac—MAPK3—MAPK Signaling Pathway—TGFB1—allergic rhinitis	2.86e-05	0.00131	CbGpPWpGaD
Sulindac—Headache—Methylprednisolone—allergic rhinitis	2.86e-05	0.000376	CcSEcCtD
Sulindac—PPARD—Gene Expression—SMAD3—allergic rhinitis	2.86e-05	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—SMAD3—allergic rhinitis	2.85e-05	0.00131	CbGpPWpGaD
Sulindac—Diarrhoea—Dexamethasone—allergic rhinitis	2.84e-05	0.000374	CcSEcCtD
Sulindac—Diarrhoea—Betamethasone—allergic rhinitis	2.84e-05	0.000374	CcSEcCtD
Sulindac—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	2.78e-05	0.00127	CbGpPWpGaD
Sulindac—Dizziness—Dexamethasone—allergic rhinitis	2.75e-05	0.000361	CcSEcCtD
Sulindac—Dizziness—Betamethasone—allergic rhinitis	2.75e-05	0.000361	CcSEcCtD
Sulindac—Nausea—Triamcinolone—allergic rhinitis	2.72e-05	0.000358	CcSEcCtD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	2.72e-05	0.00124	CbGpPWpGaD
Sulindac—Nausea—Methylprednisolone—allergic rhinitis	2.71e-05	0.000357	CcSEcCtD
Sulindac—Vomiting—Betamethasone—allergic rhinitis	2.64e-05	0.000347	CcSEcCtD
Sulindac—Vomiting—Dexamethasone—allergic rhinitis	2.64e-05	0.000347	CcSEcCtD
Sulindac—MAPK3—Signaling Pathways—PTGDR2—allergic rhinitis	2.63e-05	0.00121	CbGpPWpGaD
Sulindac—Rash—Betamethasone—allergic rhinitis	2.62e-05	0.000344	CcSEcCtD
Sulindac—Rash—Dexamethasone—allergic rhinitis	2.62e-05	0.000344	CcSEcCtD
Sulindac—Dermatitis—Betamethasone—allergic rhinitis	2.62e-05	0.000344	CcSEcCtD
Sulindac—Dermatitis—Dexamethasone—allergic rhinitis	2.62e-05	0.000344	CcSEcCtD
Sulindac—Headache—Betamethasone—allergic rhinitis	2.6e-05	0.000342	CcSEcCtD
Sulindac—Headache—Dexamethasone—allergic rhinitis	2.6e-05	0.000342	CcSEcCtD
Sulindac—MAPK3—Immune System—HLA-G—allergic rhinitis	2.59e-05	0.00118	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.58e-05	0.00118	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—TGFB1—allergic rhinitis	2.49e-05	0.00114	CbGpPWpGaD
Sulindac—Nausea—Dexamethasone—allergic rhinitis	2.47e-05	0.000324	CcSEcCtD
Sulindac—Nausea—Betamethasone—allergic rhinitis	2.47e-05	0.000324	CcSEcCtD
Sulindac—MAPK3—Signaling by GPCR—TAC1—allergic rhinitis	2.46e-05	0.00112	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—NFKB1—allergic rhinitis	2.4e-05	0.0011	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	2.38e-05	0.00109	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.3e-05	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	2.29e-05	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL5—allergic rhinitis	2.28e-05	0.00104	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TGFB1—allergic rhinitis	2.26e-05	0.00103	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—NFKB1—allergic rhinitis	2.25e-05	0.00103	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL5—allergic rhinitis	2.09e-05	0.000955	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CYSLTR1—allergic rhinitis	2.07e-05	0.000946	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL11—allergic rhinitis	2e-05	0.000914	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL5—allergic rhinitis	1.91e-05	0.000876	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.85e-05	0.000845	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NFKB1—allergic rhinitis	1.68e-05	0.00077	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQB1—allergic rhinitis	1.62e-05	0.000739	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.54e-05	0.000704	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—allergic rhinitis	1.49e-05	0.000681	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SMAD3—allergic rhinitis	1.46e-05	0.000668	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NFKB1—allergic rhinitis	1.45e-05	0.000664	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TAC1—allergic rhinitis	1.45e-05	0.000664	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TGFB1—allergic rhinitis	1.4e-05	0.000641	CbGpPWpGaD
Sulindac—MAPK3—Disease—SMAD3—allergic rhinitis	1.36e-05	0.00062	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL5—allergic rhinitis	1.35e-05	0.000617	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—NFKB1—allergic rhinitis	1.28e-05	0.000586	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—allergic rhinitis	1.21e-05	0.000553	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—allergic rhinitis	1.19e-05	0.000543	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ICAM1—allergic rhinitis	1.18e-05	0.000539	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.11e-05	0.000507	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SMAD3—allergic rhinitis	9.49e-06	0.000434	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—allergic rhinitis	8.66e-06	0.000396	CbGpPWpGaD
Sulindac—PTGS2—Disease—SMAD3—allergic rhinitis	8.06e-06	0.000369	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—allergic rhinitis	8e-06	0.000366	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NFKB1—allergic rhinitis	7.46e-06	0.000342	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—allergic rhinitis	5.74e-06	0.000263	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—allergic rhinitis	5.7e-06	0.000261	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NFKB1—allergic rhinitis	4.83e-06	0.000221	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—allergic rhinitis	4.76e-06	0.000218	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—allergic rhinitis	4.02e-06	0.000184	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—allergic rhinitis	3.41e-06	0.000156	CbGpPWpGaD
